Metagenomi Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MGX | MTVA | MREO | EDIT | DTIL | PRQR | |
|---|---|---|---|---|---|---|
| Market cap | 29.84M | 8.83M | 48.40M | 417.74M | 226.84M | 198.98M |
| P/E (TTM) | — | — | — | — | 32.5 | — |
| Forward P/E | -0.4 | — | -13.1 | -3.6 | -4.4 | -3.0 |
| Price/book | 0.3 | 1.3 | 1.7 | 4.0 | 4.4 | 2.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −64.41% | −85.67% | −82.78% | +1.12% | +26.09% | −36.20% |
| Today | +3.95% | +6.35% | +4.16% | +4.62% | +16.50% | +2.92% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MGX news ›Alma Therapeutics partnership to advance translational research
“Translational research powered by fundamental scientific breakthroughs continues to be vital to addressing the challenges facing human health,” said Susan Martinis, senior vice chancellor for research and innovation at the U. of I. “Alma…
Metagenomi Details Hemophilia A Gene-Insertion Plans at Chardan Conference
Posted by Sarita Garza on Oct 26th, 2026 Chardan Senior Biotech Analyst Keay Nakae said traditional CRISPR approaches use guide RNA to direct an enzyme to a DNA location, where it creates a double-stranded break. The panel examined…
Center for NextGen Therapeutics
According to Dr. Deshaies, the biopharmaceutical industry has undergone four transformative waves over the past century. The first wave combined chemistry... Center for NextGen Therapeutics According to Dr. Deshaies, the biopharmaceutical…
Modus Therapeutics
The Pharma Letter Modus is based in Stockholm, and its shares have traded on the Nasdaq First North Growth Market there since July 2021. Its clinical work runs abroad: the CKD study is at two nephrology centers in Italy, in Verona and…
Metabolize Raises $3.2 Million Seed Led By Astanor For Precision Metabolite Technology
Metabolize has raised $3.2 million in seed financing to accelerate commercialization of its Precision Metabolite Technology and support the development, validation, and manufacturing of metabolic health products based on Stanford…
Metabolize Raises $3.2 Million Seed Financing to Accelerate Science-Backed Solutions for Metabolic Health
BioSpace Metabolize Raises $3.2 Million Seed Financing to Accelerate Science-Backed Solutions for Metabolic Health The investment will support the launch of NATLEAN in January 2027 and expand M
LifeMine Therapeutics Forms Clinical Advisory Board of Leading Experts in Organ Transplantation
BioSpace LifeMine Therapeutics Forms Clinical Advisory Board of Leading Experts in Organ Transplantation Clinical advisory board brings together world renowned transplant surgeons and physicians to suppo
Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference
The Manila Times Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference EMERYVILLE, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: M
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Editas Medicine (EDIT) will present two posters at the European Society of Gene and Cell Therapy Congress on October 28, 2026. Editas Medicine (EDIT) will present two posters at the European Society of Gene and Cell Therapy Congress on…
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
MELBOURNE, Australia and SAN FRANCISCO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ('Alterity” or 'the Company”), a biotechnology company dedicated to developing disease modifying treatments for…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- manilatimes.net4
- stocktitan.net2
- bcm.edu1
- biospace.com1
- globenewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.